(Albany, USA) DelveInsight’s “Anemia in Elderly Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Anemia in Elderly, historical and forecasted epidemiology as well as the Anemia in Elderly market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

To know more about the Anemia in Elderly market report offering, download sample report @ Anemia in Elderly Market Forecast

 

Key highlights of Anemia in Elderly Market Report are:

• According to DelveInsight, the Anemia in Elderly market size is expected to grow at a decent CAGR by 2032.
• Leading Anemia in Elderly companies working in the market are Amag Pharmaceuticals, Vifor Pharma Inc., Rockwell Medical, Keryx Biopharmaceuticals Inc., Sanofi-Aventis U.S., Shield Therapeutics Plc., Pharmacosmos A/S, American Regent/Vifor, Amgen Inc, Japan Tobacco, Fibrogen/Astrazeneca, Glaxosmithkline, Akebia Therapeutics, Bioage Labs Inc., Nemysis, Megapro Biomedical, Bayer And Others.
• Anemia’s prevalence rate in the elderly population is estimated to be 10% in the United States and Europe. This estimation increases further with age greater than 80 years and among hospitalized patients or residents at nursing homes (Guralnik et al., 2004; Petrosyan et al., 2012).
• In 2018, the prevalent population of Anemia in the Elderly (65+) in the United States was found to be 5,557,706 .
• Assessments as per DelveInsight’s analysts showed that there were 4,586,079 mild, 855,032 moderate, and 116,595 severe Anemia cases in the United States in 2018.
• Assessments as per DelveInsight’s analysts showed that in 2018, the IV treated postoperative patients in the United States was 123,119 which expected to increase to 169,476 by 2030. 

 

Key benefits of the Anemia In Elderly Market report:

• Anemia In Elderly market report covers a descriptive overview and comprehensive insight of the Anemia In Elderly Epidemiology and Anemia In Elderly market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
• The Anemia In Elderly market report provides insights on the current and emerging therapies.
• Anemia In Elderly market report provides a global historical and forecasted market covering drug outreach in 7MM.
• The Anemia In Elderly market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Anemia In Elderly market.

 

Download the report to understand which factors are driving Anemia In Elderly epidemiology trends @ Anemia In Elderly Epidemiological Insights

 

Anemia In Elderly Epidemiology

The Anemia In Elderly epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The Anemia In Elderly epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Anemia In Elderly Epidemiology Segmentation:

The Anemia In Elderly market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Anemia In Elderly
• Prevalent Cases of Anemia In Elderly by severity
• Gender-specific Prevalence of Anemia In Elderly
• Diagnosed Cases of Anemia In Elderly

 

Download free sample report to know more about recent developments in Anemia In Elderly treatment market, visit @ Anemia In Elderly Clinical Trials 

 

Anemia In Elderly Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Anemia In Elderly market or expected to get launched during the study period. The analysis covers Anemia In Elderly market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Anemia In Elderly Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Anemia In Elderly market share @ Anemia In Elderly market forecast

 

Anemia In Elderly Therapies and Companies working in the market:

• Feraheme (Ferumoxytol Injection): Amag Pharmaceuticals
• Venofer (Iron Sucrose): Vifor Pharma Inc.           
• Triferic (Ferric Pyrophosphate Citrate): Rockwell Medical
• Auryxia (Ferric Citrate): Keryx Biopharmaceuticals Inc.
• Ferrlecit (Sodium Ferric Gluconate Complex In Sucrose Injection): Sanofi-Aventis U.S.
• Accrufer/Feraccru (Ferric Maltol): Shield Therapeutics Plc.
• Monoferric (Ferric Derisomaltose): Pharmacosmos A/S
• Injectafer (Ferric Carboxymaltose Injection): American Regent/Vifor
• Procrit (Epoetin Alfa): Amgen Inc
• Enaroy (Enarodustat): Japan Tobacco
• Roxadustat: Fibrogen/Astrazeneca
• Daprodustat: Glaxosmithkline
• Vadadustat: Akebia Therapeutics
• Bge-117: Bioage Labs Inc.
• Idax (Ihat-02): Nemysis
• Mpb-1514: Megapro Biomedical
• Molidustat (Bay85-3934): Bayer

 

Scope of the Anemia In Elderly Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Anemia In Elderly Companies: Amag Pharmaceuticals, Vifor Pharma Inc., Rockwell Medical, Keryx Biopharmaceuticals Inc., Sanofi-Aventis U.S., Shield Therapeutics Plc., Pharmacosmos A/S, American Regent/Vifor, Amgen Inc, Japan Tobacco, Fibrogen/Astrazeneca, Glaxosmithkline, Akebia Therapeutics, Bioage Labs Inc., Nemysis, Megapro Biomedical, Bayer And Others.
• Anemia In Elderly Therapeutic Assessment: Anemia In Elderly current marketed and Anemia In Elderly emerging therapies
• Anemia In Elderly Market Dynamics: Anemia In Elderly market drivers and Anemia In Elderly market barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Anemia In Elderly Unmet Needs, KOL’s views, Analyst’s views, Anemia In Elderly Market Access and Reimbursement

 

Download Anemia in Elderly sample report for free to get detailed insights into Anemia in Elderly companies and treatment market

 

Table of Contents

1. Key Insights

2. Executive Summary of Anemia in Elderly

3. Competitive Intelligence Analysis for Anemia in Elderly

5. Anemia in Elderly: Disease Background and Overview

6. Anemia in Elderly Patient Journey of Anemia in Elderly

7. Anemia in Elderly Epidemiology and Patient Population

8. Anemia in Elderly Treatment Algorithm, Current Treatment, and Medical Practices

9. Anemia in Elderly Unmet Needs

10. Key Endpoints of Anemia in Elderly Treatment

11. Marketed Anemia in Elderly Products

12. Emerging Anemia in Elderly Therapies

13. Anemia in Elderly: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Anemia in Elderly Market Outlook

16. Access and Reimbursement Overview of Anemia in Elderly

17. Anemia in Elderly KOL Views

18. Anemia in Elderly Market Drivers

19. Anemia in Elderly Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting